19-57620444-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003435.5(ZNF134):c.325G>A(p.Asp109Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000204 in 1,614,174 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003435.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF134 | NM_003435.5 | c.325G>A | p.Asp109Asn | missense_variant | 3/3 | ENST00000396161.10 | NP_003426.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF134 | ENST00000396161.10 | c.325G>A | p.Asp109Asn | missense_variant | 3/3 | 1 | NM_003435.5 | ENSP00000379464.4 | ||
ZNF134 | ENST00000597975.1 | n.556G>A | non_coding_transcript_exon_variant | 2/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000168 AC: 42AN: 249586Hom.: 0 AF XY: 0.000214 AC XY: 29AN XY: 135408
GnomAD4 exome AF: 0.000203 AC: 297AN: 1461892Hom.: 0 Cov.: 32 AF XY: 0.000205 AC XY: 149AN XY: 727248
GnomAD4 genome AF: 0.000217 AC: 33AN: 152282Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.325G>A (p.D109N) alteration is located in exon 3 (coding exon 2) of the ZNF134 gene. This alteration results from a G to A substitution at nucleotide position 325, causing the aspartic acid (D) at amino acid position 109 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at